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Abstract
Background: CD40–CD154 interactions have proven critical in autoimmunity, with the identification of CD4
loCD40
+ T cells
(Th40 cells) as harboring an autoaggressive T cell population shedding new insights into those disease processes. Th40 cells
are present at contained levels in non-autoimmune individuals but are significantly expanded in autoimmunity. Th40 cells
are necessary and sufficient in transferring type 1 diabetes in mouse models. However, little is known about CD40 signaling
in T cells and whether there are differences in that signaling and subsequent outcome depending on disease conditions.
When CD40 is engaged, CD40 and TNF-receptor associated factors, TRAFs, become associated with lipid raft microdomains.
Dysregulation of T cell homeostasis is emerging as a major contributor to autoimmune disease and thwarted apoptosis is
key in breaking homeostasis.
Methodology/Principal Findings: Cells were sorted into CD4
hi and CD4
lo (Th40 cells) then treated and assayed either as
whole or fractionated cell lysates. Protein expression was assayed by western blot and Nf-kB DNA-binding activity by
electrophoretic mobility shifts. We demonstrate here that autoimmune NOD Th40 cells have drastically exaggerated
expression of CD40 on a per-cell-basis compared to non-autoimmune BALB/c. Immediately ex-vivo, untreated Th40 cells
from NOD mice have high levels of CD40 and TRAF2 associated with the raft microdomain while Th40 cells from NOR and
BALB/c mice do not. CD40 engagement of Th40 cells induces Nf-kB DNA-binding activity and anti-apoptotic Bcl-XL
expression in all three mouse strains. However, only in NOD Th40 cells is anti-apoptotic cFLIPp43 induced which leads to
preferential survival and proliferation. Importantly, CD40 engagement rescues NOD Th40 cells from Fas-induced death.
Conclusions/Significance: CD40 may act as a switch between life and death promoting signals and NOD Th40 cells are
poised for survival via this switch. This may explain how they expand in autoimmunity to thwart T cell homeostasis.
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Introduction
The role of CD40–CD154 interactions in autoimmune diseases
[1,2] including type I diabetes (T1D) [3–5], collagen induced
arthritis [6,7], systemic lupus erythamotosis [8,9], and autoimmune
thyroiditis[10],hasbeenwelldocumented.CD40(tnfrsf5)belongsto
the TNF-receptor family and when CD40 is engaged it becomes
associated with lipid rafts to interact with the adaptor molecules,
TNF receptor associated factors (TRAFs), for downstream signaling
[11]. CD40 expression has traditionally been associated with B cells,
dendritic cells and macrophages (antigen presenting cells, APC) [12]
but has proven to be more ubiquitous and now has been described
on T cells [6,12–16]. In autoimmunity there is an expansion of a
CD40-expressing T cell subset that also is characterized by its low
surface-expression of CD4 [4,15–17].
While the consequences of CD40 signals in APC have been
extensively studied [12,18–20] little is known about the outcome of
CD40 signals in T cells. Specifically, do differences exist in the
signaling outcome between autoimmune and non-autoimmune
conditions? We previously demonstrated that CD40 engagement of
aCD 4
+CD40
+Tcellclone,BDC2.5,induced rapidactivationofNf-
kB DNA binding activity [16] as well as induction of RAG1 and
RAG2 expression, the proteins necessary for TCR expression [3].
RecentlyitwasshownthatengagementofCD40onTcellscanserve
a costimulatory function [6]. The CD4
loCD40
+ Tc e l l s ,w h i c hw e
termed Th40 cells, are detected in diabetic and prediabetic NOD
mice as well as innon-autoimmune controls[4,15]. Interestingly, the
Th40 cell subset is greatly expanded under autoimmune conditions
and is necessary and sufficient in diabetes transfers from the non-
obese diabetic (NOD) mouse to NOD.scid animals [4,15,16]. The
expansion seen in autoimmune prone animals can be prevented by
blocking CD40–CD154interactions[4].While theidentical subset is
present in non-autoimmune subjects, it remains contained at lower
percentages of total lymphocytes [4,15,16].
Although the cause for peripheral T cell autoaggression in
autoimmune disease [16,21–25] is not fully understood, dysreg-
ulation of T cell control is emerging as a major contributor
[4,26,27]. Specifically, loss of homeostasis between regulatory T
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autoaggressive Th40 cells [4], is taking center stage. Homeostatic
regulation of T cells is dependent on apoptosis [28,29] and
thwarted apoptosis of peripheral effector T cells is a key element in
autoimmunity [28]. For example, mice deficient in Fas - FasL
develop autoimmunity [30]. Events, such as engagement of death
receptors ( e.g. Fas, TRAIL, TNF-R; i.e. extrinsic pathway) or loss
of mitochondrial potential followed by release of cytochrome c (i.e.
intrinsic pathway), can lead to apoptosis. The Bcl protein family
(including anti-apoptotic Bcl-2 and Bcl-XL and pro-apoptotic Bax
and Bak) is involved in pro- and anti-apoptotic events in the
intrinsic pathway while cFLIP, a homolog of caspase-8 and FADD
that can act as a caspase-8 decoy, is involved in the extrinsic
pathway [28,29,31,32]. cFLIP can be both pro- and anti-apoptotic
[33] but it can be cleaved to generate anti-apoptotic cFLIPp43 that
interacts with TRAF2 and induces Nf-kB activation [34]. The two
apoptotic pathways also converge as it was shown that Bcl-XL
expression affects the extrinsic pathway partly by inducing cFLIP
expression [35].
Because we demonstrated a causal relationship of CD40–CD154
interactions leading to expansion of potentially autoaggressive Th40
cells in vivo [4], we investigated whether CD40-signals directly to the
T cell can be responsible for such an expansion. Therefore we
compared CD40 expression and signaling outcomes between
autoimmune and non-autoimmune conditions as well as between
Th40 cells and CD4
hi T cells within those conditions.
Here we show that Th40 cells from NOD, NOR and BALB/c
mice have differences in CD40 protein expression levels as well as
differences in CD40 and TRAF2 association with the raft
microdomain. Immediately ex-vivo NOD Th40 cells are poised for
CD40 signaling by having high amounts of CD40 and TRAF2
associated with the raft microdomain and induce high levels of Nf-
kB activation as well as anti-apoptotic cFLIPp43 and Bcl-XL protein
expression in response to CD40 engagement. CD40 engagement of
NOD Th40 cells increases survival and induces proliferation. CD40
engagement also rescues those cells from Fas-induced death. CD40-
induced cFLIPp43 expression inNOD Th40 cells persists when Fas is
simultaneously engaged. The same subsets from non-autoimmune
NOR and BALB/c mice exhibit a difference in total levels of CD40
compared to each other but they both induce Bcl-XL expression.
However, neither NOR nor BALB/c T cells induce cFLIPp43
expression or proliferate in response to CD40 engagement.
Therefore it is possible that CD40, via cFLIPp43, acts as a switch
between Fas-induced cell death and survival/proliferation of these
cells in autoimmunity. The results, together with our previous report
that in vivo blockade of CD40–CD154 interaction in NOD prevents
the expansion of potentially autoaggressive Th40 cells [4], suggest
that a fundamental difference in CD40 expression and signaling
leads to dysregulation of peripheral T cell control and may be a
major cause for disease progression in autoimmunity.
Results
Magnetic CD4 sort effectively purifies splenic cells into
CD4
lo (Th40 cells) and CD4
hi T cells
We have previously purified CD4
lo and CD4
hi T cells by flow
cytometric sorting [3]. However, this method is costly and time
consuming which lead us to develope a magnetic sort (detailed in
the methods section) that yielded CD4
lo and CD4
hi T cells. We
determined levels of T cell associated molecules in the CD4
lo
population. CD4
lo T cells from both NOD and BALB/c mice
expressed CD4 and CD3 (Figure S1A–D). However, portions of
those proteins were contained intracellularly (Figure S1A–D).
Additionally, CD4
lo cells from both strains of mice expressed
CD28 at similar mean fluorescence intensities as CD4
hi T cells
(Figure S1E). The CD4
lo cells were further categorized as T cells
by staining and RT-PCR for TCR. CD4
lo cells from NOD and
BALB/c mice exhibited expression of an array of both TCRb and
TCRa molecules (Figure S2A and B). Additionally, CD4
lo T cells
express IFNc when activated (data not shown).
To address the possibility of B cell contamination the B cell
specific proteins CD19 and CD21 were stained on CD4
lo, CD4
hi,
and depleted cells (MHCII
+, CD8
+, and CD25
+ cells; removed by
sorting). The CD4
lo and CD4
hi T cell populations exhibited very
low B cell contamination (Figure S3A). As expected, the majority
of the depleted cells (MHCII
+CD8
+CD25
+) expressed CD19 and
CD21 (Figure S3A). We further determined levels of CD11b and
CD11c which are mainly associated with monocytes/macrophages
and dendritic cells, respectively, but have also been shown to be
expressed by subsets of T cells [36–38]. A small portion of CD4
lo
T cells from both NOD and BALB/c expressed CD11b (Figure
S3B). In addition, when cultured in tissue culture flasks the CD4
lo
T cells take on a morphology like that of T cell clones and the size
of CD4
lo T cells, when activated, never increases like that of
activated antigen presenting cells (data not shown).
NOD CD4
lo T cells express high levels of CD40
We have shown that CD4
loCD40
+ Tc e l l sa r ee x p a n d e di n
autoimmune prone mice[4,15,16] aswellasin human T1D patients
[17]. Therefore we determined whether there is also a difference on
a per-cell basis in CD40 expression in those cells comparing
autoimmune prone NOD to non-autoimmune BALB/c and NOR
mice. NOR miceare diabetes resistant but contain greaterthan 90%
of the NOD genome, including the unique IA
g7 MHCII [39]. Cells
from NOD, NOR, and BALB/c mice were sorted into CD4
lo and
CD4
hi T cells. In immediately ex-vivo CD4
lo cells from NOD mice
CD40 expression was 12-fold higher than that in the same subset
from BALB/c mice (Figure 1A and C) and 2-fold higher than that of
NOR (Figure 1A–C; note that the standard in the NOR experiment
(B) is more intense than the standard in the NOD and BALB/c
experiment(A)). CD4
hiT cells fromallthree mouse strains expressed
CD40 at a lower level than CD4
lo T cells but, by direct comparison,
CD4
hi T cells from NOD mice had higher CD40 levels than NOR
and BALB/c CD4
hi T cells (about 2.5-fold; Figure 1A–C). When
CD40 wasengagedfor20 hrs,bothpopulationsfromNOD,BALB/
c, and NOR mice induced an increase in CD40 expression
demonstrating a positive feedback loop.
CD40 signals aid in survival of NOD Th40 cells in vitro
Th40 cells are expanded in autoimmune mouse strains [4,15]
and that expansion is prevented in NOD mice by blocking CD40–
CD154 interactions [4]. Therefore we determined whether CD40
signals lead directly to increased survival of Th40 cells in vitro and
whether there is a difference between autoimmune and non-
autoimmune derivation of the Th40 cells.
Sorted Th40 cells (CD4
lo) and CD4
hi T cells, from spleens of
NOD, NOR and BALB/c mice, were cultured in the absence or
presence of CD40-, Fas- or (CD40+Fas)-engagement then absolute
numbers of live cells were counted after 1, 2, and 3 days of culture.
It was evident that CD40 engaged NOD Th40 cells, compared to
untreated, survived more readily over 3 days (Figure 2A). In fact,
the number of cells doubled. In contrast there was no clear benefit
of CD40 engagement in the same population from BALB/c mice
(Figure 2B). Th40 cells from NOR survived better, compared to
untreated, when CD40 engaged (Figure 2C). However, the
survival induced by CD40 declined with time (Figure 2C). When
Fas was engaged on NOD Th40 cells, cell death was induced
(Figure 2A). Interestingly, if CD40 was engaged simultaneously
Autoaggressive T Cell Survival
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on day 1 (Figure 2A; p,0.001, t-test) persisting even 3 days after
stimulation (Figure 2A; p,0.05, t-test). Similarly, NOR Th40 cells
were rescued from Fas induced death by CD40 engagement but
the absolute number of cells from NOD mice that survived was 1.5
times greater than those from NOR mice after 3 days (Figure 2A
and C). The same type of rescue was not detected in BALB/c
Th40 cells (Figure 2B). In NOD CD4
hi T cells, CD40 engagement
led to somewhat increased survival (Figure 2D). However, this
survival was not accompanied by a drastic increase in the number
of cells. While there was a CD40-induced rescue from Fas death in
the NOD CD4
hi population on day 1 (Fig. 2D; p,0.05, t-test),
that rescue was not sustained on day 3 (p.0.6, t-test). BALB/c and
NOR CD4
hi T cells did not preferentially survive in response to
CD40 signals (Fig. 2E and F). These data demonstrate a crucial
CD40 signaling difference, relative to cell survival, in the
potentially autoaggressive Th40 cell population between autoim-
mune and non- autoimmune conditions.
Potentially autoaggressive Th40 cells from NOD
proliferate in response to CD40 engagement
Because the NOD Th40 cells readily survived and nearly
doubled in numbers in response to CD40 signals in vitro,w e
determined the effect of CD40 engagement on proliferation.
Untreated NOD Th40 cells underwent minimal proliferation over
3 days in culture (Fig. 3, UN). However, when cells were CD40
engaged for 3 days significant proliferation was seen (Fig. 3,
CD40). When NOD Th40 cells were Fas engaged, the minimal
proliferation seen in untreated cells was reduced (Fig. 3, compare
UN and Fas). When CD40 was engaged simultaneously with Fas,
NOD Th40 cells proliferated to the same extent as untreated cells
but not to the extent seen with CD40 treatment alone (Fig. 3). This
demonstrates that although CD40 signals thwarted Fas-induced
death, as seen in figure 2, Fas signals ablated the proliferation seen
in CD40 stimulated NOD Th40 cells. Unlike T cells from NOD
mice, NOR and BALB/c Th40 cells did not proliferate in
response to CD40 (Fig. 3, compare UN and CD40). Additionally,
CD4
hi T cells from NOD, but not NOR and BALB/c mice,
demonstrated some proliferation in response to CD40 engagement
(Fig. 3, CD40). However, this did not lead to a significant
expansion of these cells as shown in figure 2.
These data demonstrate that CD40 engagement alone can drive
not only survival but also expansion of the potentially autoag-
gressive Th40 cells in autoimmune NOD, but not in non-
autoimmune NOR and BALB/c mice. These intrinsic differences
relative to CD40, and now Fas, signaling suggest a mechanism to
promote autoimmunity.
Figure 1. NOD Th40 cells express high levels of CD40 compared to BALB/c. Immediately ex-vivo, magnetically sorted Th40 cells and CD4
hi T
cells from age matched 8–12 week-old female NOD (euglycemic), BALB/c or NOR were either immediately lysed (Imm. ex-vivo) or cultured overnight
in the absence (UN) or presence of CD40 engagement (CD40) then lysed. Whole cell extracts, 5 mg, were analyzed by western blot for CD40. As an
internal standard for loading (std) the membranes were stripped and stained with coomassie blue and a representative band is shown. (A) Western
blot for CD40 in Th40 cells and CD4
hi T cells from NOD and BALB/c. (B) Western blot for CD40 in Th40 cells and CD4
hi T cells from NOR. (C) Graph
representing the data in A and B. Data in C are represented as mean6SEM from at least 3 separate experiments.
doi:10.1371/journal.pone.0002076.g001
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different between autoimmune and non-autoimmune
Th40 cells
When CD40 is engaged on both B and T cells it becomes
associated with lipid raft microdomains to interact with adaptor
molecules, TRAFs, for downstream signaling [6,11]. Therefore we
determined whether CD40 became associated with the detergent-
insoluble raft fraction in the Th40 cells and CD4
hi T cells from
NOD, NOR, and BALB/c mice when CD40 was engaged.
Strikingly, a large amount of CD40 was associated with the raft
fraction in immediately ex-vivo NOD Th40 cells compared to only a
small amount in Th40 cells from NOR and BALB/c (insoluble
fraction; Fig. 4A). When CD40 was engaged, this association
Figure 2. CD40 engagement of NOD Th40 cells induces increased survival. Sorted Th40 cells and CD4
hi T cells from age matched 8–12
week-old female NOD (euglycemic), NOR or BALB/c were untreated (UN), CD40-crosslinked (CD40), Fas crosslinked (Fas) or (CD40+Fas)-crosslinked
((CD40+Fas)) for 1, 2 and 3 days. Absolute numbers of live cells were counted by trypan blue exclusion. (A) NOD CD4
lo.( B) BALB/c CD4
lo.( C) NOR
CD4
lo.( D) NOD CD4
hi.( E) BALB/c CD4
hi.( F) NOR CD4
hi. Data are represented as mean6SEM from 3 separate experiments.
doi:10.1371/journal.pone.0002076.g002
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CD4
hi T cells from NOD and BALB/c mice, association of some
CD40 with the raft fraction was observed while in the same subset
from NOR mice CD40 was not detected in this fraction (Fig. 4B).
CD40 engagement of CD4
hi T cells from both NOD and BALB/c
mice sustained the association of CD40 with the raft fraction
(Fig. 4B). These data demonstrate that, given the immediately ex-vivo
data, NOD Th40 cells likely are CD40 engaged in vivo. Therefore
these cells may be poised for survival and proliferation should they
encounter death promoting signals such as Fas stimulation.
TRAFs, including TRAF2, function as CD40 signal adaptor
molecules in both B and T cells and associate with lipid raft
microdomains upon CD40 stimulation [6,11,40]. Therefore we
determined if TRAF2 was present in the raft fraction, setting the
stage for CD40 signaling. TRAF2 was strongly associated with the
raft fraction in NOD Th40 cells and remained associated during
culture regardless of stimulation (Fig. 4C). However, in NOR and
BALB/c Th40 cells, only a small amount of TRAF2 was
associated with the raft fraction immediately ex-vivo (Fig. 4C). In
CD4
hi T cells from all three mouse strains smaller amounts of
TRAF2 associated with the raft fraction compared to that seen in
the Th40 cells (Fig. 4D compared to C). NOD CD4
hi T cells had
higher amounts compared with NOR and BALB/c CD4
hi T cells
(Fig. 4D). This demonstrates that NOD Th40 cells have the
signaling machinery necessary to transmit CD40 signals associated
with the raft microdomain immediately ex-vivo. This could be due
to the high availability of CD154 in autoimmunity [1,41–44] that
can constantly engage CD40 on these T cells.
Figure 3. CD40 engagement of NOD Th40 cells induces proliferation. Sorted Th40 cells and CD4
hi T cells from age matched 8–12 week-old
female NOD (euglycemic), NOR or BALB/c were labelled with CFSE and were then untreated (UN), CD40-crosslinked (CD40), Fas-crosslinked (Fas) or
(CD40+Fas)-crosslinked ((CD40+Fas)) for 1, 2 and 3 days. T cell proliferation was assessed by CFSE dilution on day 1 (filled histogram), day2 (solid line)
and day 3 (dashed line) in FACS analysis on ungated cells. Percentages represent amount of cells that proliferated on day 3 and are represented as
mean6SEM from 3 separate experiments.
doi:10.1371/journal.pone.0002076.g003
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expression of Bcl-XL in Th40 cells but only NOD Th40 cells
induce cFLIPp43
Increased expression of anti-apoptotic factors such as Bcl-XL,
which affects the intrinsic pathway, have been implicated in
decreased apoptosis. Autoimmune diseases characteristically main-
tain T cells that are resistant to cell death [45–47]. Cleaved cFLIP
(cFLIPp43) is protective in the extrinsic pathway and interacts with
TRAF2 to induce Nf-kB activation [34]. Given that NOD Th40
cells readily survive in response to CD40 engagement we examined
whether there were differences in Bcl-XL and cFLIP expression
between Th40 cells from NOD, NOR and BALB/c mice.
A basal level of Bcl-XL was apparent in both NOD and BALB/c,
but not in NOR, Th40 cells (Fig. 5A and Figure S4). CD40
engagementinduced high Bcl-XL proteinexpression inNOD as well
as NOR Th40 cells. In BALB/c Th40 cells more modest levels of
Bcl-XL were induced (Fig. 5A and Figure S4). CD4
hi Tc e l l sf r o m
NOD and NOR mice induced fairly high expression of Bcl-XL in
response to CD40 engagement although not as high as those of the
respective Th40 cell subsets (Fig. 5A and B and Figure S4).
Meanwhile, BALB/c CD4
hi T cells induced only low levels of Bcl-
XL (Fig. 5B and Figure S4). Interestingly, the CD40-induced Bcl-XL
expression was sustained in both cell subsets from all three mouse
strains even when Fas was engaged simultaneously (Fig. 5A and B
and Figure S4). Additionally, NOR CD4
hi T cells induced low levels
of pro-apoptotic Bcl-XS in response to Fas engagement (Figure 5B).
When examining cFLIP levels, NOD Th40 cells exhibited a
basal expression of cFLIPp43, the activated, protective form of
cFLIP (Figure 5C). When CD40 engaged, NOD Th40 cells
induced higher expression of cFLIPp43 and this higher expression
was sustained with simultaneous Fas engagement (Figure 5C). In
NOR and BALB/c Th40 cells, however, only cFLIPL was
expressed and none of the treatments induced cFLIPp43
(Figure 5C). In CD4
hi T cells from NOD, NOR and BALB/c
mice, a low basal level of cFLIPL was observed but only in NOD
CD4
hi T cells was cFLIPp43 expression induced in response to
CD40 engagement (Figure 5D). The induced cFLIPp43 expression
was not sustained when Fas was simultaneously engaged.
The data demonstrate that CD40 successfully signals to both
Th40 and CD4
hi T cell subsets in NOD, NOR, and BALB/c mice
to induce Bcl-XL expression. That induced expression appears
independent of Fas signals. In the highest expressors, i.e. Th40
cells from NOD and NOR, Bcl-XL expression appears to protect
against Fas induced cell death. However, over time NOD Th40
cells appear to survive more readily (Figure 2) perhaps due to the
high levels of induced cFLIPp43. In one of the moderate expressors
of Bcl-XL, i.e. CD4
hi T cells from NOD, CD40 engagement
initially induces rescue from Fas death. However, with time and
with CD40 induced cFLIPp43 expression being all but thwarted
when Fas was engaged simultaneously, the benefit is no longer
there. NOR CD4
hi T cells are also moderate Bcl-XL expressors
but are not rescued from Fas death by CD40 engagement. This is
perhaps due to that Bcl-XS, a pro-apoptotic protein, is induced by
Figure 4. Immediately ex-vivo NOD Th40 cells have CD40 and TRAF2 associated with rafts. Sorted Th40 cells and CD4
hi T cells from age
matched 8–12 week-old female NOD (euglycemic), BALB/c or NOR were immediately lysed (Imm. ex-vivo) or untreated (UN), CD40-crosslinked (CD40),
Fas-crosslinked (Fas) or (CD40+Fas)-crosslinked ((CD40+Fas)) for 5 hours then soluble (S) and insoluble (I) fractions were prepared. CD40 levels in Th40
cells and CD4
hi (A and B respectively) and TRAF2 levels in Th40 cells and CD4
hi (C and D respectively) were analyzed in western blots. CD40 was
analyzed first then the membranes were stripped and TRAF2 was analyzed. As internal loading standard (std) membranes were stripped and stained
with coomassie blue and a representative band of the same size from each membrane is shown. Data are representative of 3 separate experiments.
doi:10.1371/journal.pone.0002076.g004
Autoaggressive T Cell Survival
PLoS ONE | www.plosone.org 6 April 2008 | Volume 3 | Issue 4 | e2076Fas engagement in the NOR CD4
hi T cells. Relative to
proliferation it appears that only those cells capable of inducing
cFLIPp43 expression, i.e. NOD Th40 cells and to a lesser extent
NOD CD4
hi T cells, are able to proliferate.
Bcl-XL and cFLIP expression are dependent on Nf-kB
activation [48,49]. Since we have shown that CD40 engagement
activates Nf-kB in a T cell clone [16] we determined whether
CD40 could induce Nf-kB activation in primary T cells as well.
CD40 engagement induced Nf-kB DNA-binding activity in
primary Th40 cells from both NOD and BALB/c mice although
the induction was greater in NOD Th40 cells (Figure 6A). The
CD40-induced Nf-kB DNA-binding activity in NOD Th40 cells
was sustained when Fas was simultaneously engaged (Figure 6A).
Interestingly, in BALB/c Th40 cells, Fas engagement blocked
most of the CD40-induced Nf-kB DNA-binding activity. CD4
hi T
cells from both BALB/c and NOD mice demonstrated little or no
Nf-kB DNA-binding activity in response to CD40 engagement
(Figure 6A). When an Nf-kB inhibitor, BAY 11-7082 [50,51], was
included during the different treatments all Nf-kB DNA-binding
activity was abolished regardless of treatment and cell population
(Figure 6A, ‘‘+BAY’’).
We analyzed the levels of Bcl-XL and cFLIP in the presence of
the Nf-kB inhibitor. In the presence of BAY 11-7082 neither cell
population from NOD or BALB/c mice expressed Bcl-XL
Figure 5. CD40 engagement induces high Bcl-XL and cFLIPp43 expression in NOD Th40 cells. Sorted Th40 cells and CD4
hi T cells from age
matched 8–12 week-old female NOD (euglycemic), BALB/c or NOR were untreated (UN), CD40-crosslinked (CD40), Fas-crosslinked (Fas) or (CD40+Fas)-
crosslinked (CD40+Fas) for 20 hours. Whole cell lysates from CD4
lo T cells (A and C) or CD4
hi T cells (B and D) were analyzed in western blot for Bcl-X
or cFLIP. As internal loading standard (std), membranes were stripped and stained with coomassie blue and a representative band of the same size
from each membrane is shown. Data are representative of 3 separate experiments.
doi:10.1371/journal.pone.0002076.g005
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abolished in the presence of BAY 11-7082 while the long form of
cFLIP, cFLIPL, was more readily expressed (Figure 6D and E).
This indicates that Nf-kB DNA-binding activity is necessary for
the expression of survival proteins in response to CD40
engagement. Additionally, given the strong expression of TRAF2
Figure 6. CD40 induces Nf-kB activation in Th40 cells and Nf-kB inhibition ablates CD40-induced Bcl-XL and cFLIPp43. Sorted Th40
cells and CD4
hi T cells from age matched 8–12 week-old female NOD (euglycemic) or BALB/c were untreated (UN), CD40-crosslinked (CD40), Fas
crosslinked (Fas) or (CD40+Fas)-crosslinked ((CD40+Fas)) for 20 hours in the absence/presence of the Nf-kB inhibitor BAY 11-7082 (BAY). (A) Nuclear
extracts were analyzed in EMSA for Nf-kB DNA-binding activity using a consensus Nf-kB oligonucleotide. As controls cold Nf-kB or AP1
oligonucleotides were used in competiotion reactions. Free oligonucleotide is not shown. Data represent 3 separate experiments. (B) Whole cell
lysates from BAY 11-7082 treated NOD (B and D) or BALB/c (C and E) were analyzed in western blot for Bcl-X or cFLIP. As internal loading standard
(std), membranes were stripped and stained with coomassie blue and a representative band of the same size from each membrane is shown. Data
represent 3 separate experiments.
doi:10.1371/journal.pone.0002076.g006
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possibility for interaction of induced cFLIPp43 with TRAF2 and
further activation of Nf-kB, as has been demonstrated [34], arises.
Discussion
Recently, reports have focused on the importance of T cell
homeostasis [4,26,52–56] in protection against autoimmunity.
Although the focus has been mainly on regulatory T cells, we have
demonstrated the importance of the ratio of potentially autoag-
gressive Th40 cells to Treg [4]. In fact, we determined that an
intricate balance between Tregs and potentially pathogenic Th40
cells must be maintained to prevent autoimmunity and this process
is tightly associated with CD40 signaling [57]. Autoimmune prone
animals, and incidentally human T1D patients [17], have a
substantial abundance of peripheral Th40 cells which are highly
pathogenic in autoimmune conditions [4,15,16]. However, the
disrupted homeostasis in autoimmune prone NOD mice can be
prevented by blocking CD40–CD154 interaction [4,5]. In the
present study we further define differences in this dyad by showing
that not only are there differences in CD40 expression levels
between autoimmune and non-autoimmune conditions but the
microdomain distribution of CD40, as well as of the signaling
adaptor molecule TRAF2, is different in the potentially auto-
aggressive Th40 cell subset. The CD40 signaling outcome is
consequently different between autoimmune and non-autoim-
mune conditions. Clearly, with only the need for CD40
engagement, the Th40 cells from autoimmune prone NOD mice
are poised for survival and proliferation via activation of Nf-kB
DNA-binding activity and expression of high levels of anti-
apoptotic proteins Bcl-XL and cFLIPp43.
A striking finding is that the CD40 engaged NOD and NOR
Th40 cells could thwart Fas-induced death. However, only the
NOD Th40 cells survived and proliferated. Therefore it is possible
that CD40-induced Nf-kB activation could ultimately, via
induction of Bcl-XL expression and via decoy activity and further
Nf-kB activation by cFLIPp43, keep the culprit autoaggressive
Th40 cells resistant to death in autoimmunity and further allow
expansion of this T cell subset. Interestingly, it was shown that
NOR splenic T cells depleted of Treg transferred diabetes to
NOD.scid recipients [57,58] and we have recently transferred
diabetes to NOD.scid recipients using NOR Th40 cells [57].
Therefore it appears that NOD and NOR Th40 cells share the
CD40 hyperexpression and pathogenic TCRs that predisposes
them to become autoaggressive. However, the molecular environ-
ment in which they exist differs, as shown here, to favor CD40
signaling in NOD Th40 cells which poises them for survival and
proliferation by constantly having CD40 and TRAF2 mobilized to
the raft. Once the predisposed Th40 cells from NOR mice are
transferred into the autoimmune environment, however, they are
triggered to proliferate and become autoaggressive although at a
much slower pace than the same subset from NOD [57].
While the CD40 receptor on Th40 cells from non-autoimmune
BALB/c mice is funtional, as demonstrated by the induction of Nf-
kB activation as well as Bcl-XL expression, it was not capable of
induction of resistance to Fas death or of inducing proliferation.
This demonstrates clear mechanistic differences relative to CD40-
signaling in autoimmune versus non-autoimmune conditions.
Additionally, it indicates that the CD40-signaling pathway that
leads to cFLIPp43 expression could be targeted to control the Th40
cells in autoimmunity.
Genetic linkage studies do not indicate CD40 as a candidate gene
in autoimmunity. However, the present data demonstrate that
conditions prevailing in autoimmunity lead to hyperexpression of
CD40 on the potentially autoaggressive Th40 cell subset. This in
turn leads to alterations in the signaling of CD40 and ultimately in
life-and-death decisions in those cells. It is possible that a genetic
deviation in a different gene leads to those conditions and that CD40
therefore by proxy is a culprit in autoimmune disease.
Intrinsic Treg, i.e. specifically described as CD4
+CD25
+foxP3
+
T cells [26,52–56], which prevent autoimmune disease, are
expanded in NOD mice only after blocking CD40–CD154
interaction [4]. This together with the present data suggests that
homeostasis, specifically some maintained balance between Treg
and potentially autoaggressive Th40 cells, can be CD40 regulated
in autoimmune mice. Given the apparent hyperexpression of
CD40 on Th40 cells and the increased availability of CD154 in
autoimmune conditions [1,41–44], homeostasis can readily be
broken as has been demonstrated [4,16]. The specific conditions
leading to the observed differences are being studied and may hold
clues to how to control the culprit T cells in autoimmunity and
provide novel treatments and prevention of autoimmune disease.
Materials and Methods
Mice
NOD, NOR, and BALB/c mice from Jackson Laboratories,
Bar Harbor, Maine, were maintained under pathogen-free
conditions at the Webb-Waring Institute, University of Colorado
HSC, IACUC-approved facility. The NOD colony consistently
achieves .90% diabetes in females by the age of 18 weeks. All
experiments were carried out under IACUC-approved protocol
number 55802006(04)1E.
Antibodies and reagents
Anti-CD40 (sc-975) and anti-Bcl- XL/S (sc-634) were from Santa
Cruz Biotechnology, Inc., Santa Cruz, California, and anti-cFLIP
(F9800) from Sigma, St. Louis, MO. Biotinylated anti-Fas (Jo-2)
was from BD Biosciences, San Diego, CA. Biotinylated anti-CD40
antibodies (1C10 and 4F11) were produced in-house. Biotinylated
anti-Fas and anti-CD40 (1C10 and 4F11 always used together)
antibodies were used at 5 mg/ml each followed by 1.0 mg/ml
streptavidin to crosslink. NF-kB blocker, BAY 11-7082, was from
BIOMOL Research Laboratories, Inc., Plymouth Meeting, PA,
and was used at 10 mM. Biotinylated anti-CD25 (7D4) and anti-
CD4 (GK1.5) were produced in-house. Anti-CD8-, anti-MHCII-,
and streptavidin-conjugated magnetic microbeads were from
Miltenyi Biotec Inc., Auburn, California.
T cell purification and cell culture
Spleens from age matched female 8–12 week old NOD, NOR
and BALB/c mice were homogenized in red blood cell lysis buffer
(Sigma-Aldrich, St. Louis, Missouri) then pelleted. The cell pellet
was resuspended in 1 ml (per original spleen) PBS containing 2%
BSA and 2 mM EDTA. This buffer was used in all incubations
and washes. Biotin-anti-CD25, 1 mg/ml, was added at 20 ml/
spleen and incubated, rocking, for 15 minutes at room temper-
ature. Streptavidin-, anti-CD8-, and anti-MHCII-microbeads
were added at 20, 40, and 40 ml/spleen, respectively, and then
incubated another 15 minutes. Cells were washed once with 10 ml
buffer then sorted in ‘‘DepleteS’’ (slow-flow) mode using an
autoMACS
TM magnetic cell sorter (Miltenyi Biotec Inc., Auburn,
California). Depleted cells (CD25
2CD8
2MHCII
2) were labeled
with biotin-anti-CD4, 1 mg/ml, at 40 ml/spleen for 15 minutes
then washed once as above. Streptavidin-microbeads, 40 ml/
spleen, were added, incubated for another 15 minutes then cells
were washed once. Cells were sorted in ‘‘Possel’’ (fast-flow) in
autoMACS
TM. Magnetically positive cells were considered CD4
hi
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(CD4
loCD40
+). (While Th40 cells are magnetically CD4-negative
they do express CD4, predominantly intracellularly, CD3 and
TCR (Figure S1 and Figure S2).) Cells were cultured in DMEM
containing 10% fetal calf serum and 50 mM b-mercaptoethanol.
Cells were CD40- and/or Fas-crosslinked using 5 mg/ml each of
biotinylated 1C10+4F11 and/or Fas, respectively, followed by
1.0 mg/ml of streptavidin to crosslink.
T cell survival and proliferation assays
T cells were purified as described above then cultured in the
absence/presence of CD40 crosslinking. After 1, 2, and 3 days live
cells were counted by trypan blue exclusion to determine the
survival rate. For proliferation assays the cells were labelled with
CFSE, 5 mM, crosslinked as above and assayed after 1, 2, and 3
days on a FACSCalibur flowcytometer (BD Biosciences, San
Diego, CA) for CFSE dilution.
EMSA
Nuclear protein was prepared and assayed as described [16] on T
cells that were purified and cultured as above. For the binding
reaction 1.5 mg of nuclear protein was used with a radiolabeled NF-
kB consensus oligonucleotide (Promega Corporation, Madison, WI).
Western blot
Preparation of detergent-insoluble microdomains (rafts) from
equal numbers of Th40 cells and CD4
hi T cells from NOD, NOR,
and BALB/c was done as described [6]. Briefly, 1.9610
6 cells
were lysed in 50 ml Brij-58 buffer and insoluble matter pelleted.
The pellet was then solubilized in 50 ml octylglucopyranoside
buffer. The resulting fractions were analyzed in western blots for
CD40 and TRAF2 expression (10 ml/lane). Preparation of whole
cell lysates from Th40 cells and CD4
hi cells was done by lysis in
buffer (1% Triton X-100, 150 mM NaCl, 20 mM Tris, pH 7.5,
2 mM EDTA, 1 mg/ml each aprotinin and leupeptin, 0.4 mM
PMSF, 0.4 mM sodium-ortho-vanadate, 0.5 mM DTT) for
10 minutes at room temperature then insoluble debris was
pelleted. Bcl-X and cFLIP levels were analyzed by western blot,
10 mg protein/lane [3]. As internal loading standard, membranes
were stripped and stained with Coomassie Blue R-250. Analysis of
band intensities was done with Kodak 1D densitometry analysis
software (Eastman Kodak Company, Rochester, New York).
Supporting Information
Figure S1 CD4
lo cells express T cell associated proteins CD4,
CD3 and CD28. NOD and BALB/c splenic cells were
magnetically sorted into CD4
lo and CD4
hi populations as detailed
in the methods section. (A) CD4
lo and CD4
hi cells were either
stained immediately after sort (black lines) or cultured overnight
then stained for CD4 (dashed lines). Grey-shaded histogram is
isotype control. (Staining after overnight culture was done because
the CD4-molecule on the CD4
hi cells was somewhat blocked for
stain by the antibody used for sort (GK1.5). It is known that the
antibody used for staining here (H129.19; CyChrome-conjugated
from BD Bioscience) competes with the GK1.5 antibody.)
Percentages on the left represent the amount of cells staining in
the CD4-low range (M1) and on the right the amount of cells
staining in the CD4-high range (M2) after overnight culture.
Events were ungated. (B) Western blot for CD4 on whole cell
extracts (10 ug/lane) from CD4
lo and CD4
hi cells was performed
on cells immediately after sort using CD4 antibody (sc-1140) from
Santa Cruz Biotechnology, Inc. As a loading control membranes
were stripped and coomassie blue stained and a representative
band is shown (std). (C) CD4
lo and CD4
hi cells were stained
immediately after sort for CD3-e (145.2C11; CyChrome-conju-
gated from BD Bioscience; black line). Grey-shaded histogram is
isotype control. Percentages on the left represent the amount of
cells staining in the CD3-low range (M1) and on the right the
amount of cells staining in the CD3-high range (M2). Events were
ungated. (D) Western blot for CD3, using CD3 antibody (sc-1127)
from Santa Cruz Biotechnology, performed as above. (E) CD4
lo
(black line) and CD4
hi (dashed line) cells were stained for CD28
(37.51; PE-conjugated from eBioscience) immediately after sort.
Grey-shaded histogram is isotype control. Percentages represent
the amount of cells staining in M1. Events were ungated.
Found at: doi:10.1371/journal.pone.0002076.s001 (0.53 MB PPT)
Figure S2 CD4
lo cells express T cell receptor a and b. NOD and
BALB/c splenic cells were magnetically sorted into CD4
lo and
CD4
hi populations as detailed in the methods section. (A) CD4
lo
and CD4
hi cells were stained immediately after sort for TCRb
(H57-597; CyChrome-conjugated from BD Bioscience; black line).
Grey-shaded histogram is isotype control. Percentages on the left
represent the amount of cells staining in the TCR-low range (M1)
and on the right the amount of cells staining in the TCR-high
range (M2). Events were ungated. (B) RT-PCR was performed on
RNA from CD4
lo and CD4
hi cells from NOD and BALB/c using
TCR Va specific primers (Blish, C. A., B. J. Gallay, et al. (1999). J
Immunol 162(6): 3131–40) or TCR Vb specific primers (DiLor-
enzo, T. P., R. T. Graser, et al. (1998). Proc Natl Acad Sci U S A
95(21): 12538–43). Each lane had cDNA-starting-material equiv-
alent to 750 cells.
Found at: doi:10.1371/journal.pone.0002076.s002 (4.68 MB PPT)
Figure S3 CD4
lo T cells are not contaminated by B cells and a
portion of the CD4
lo T cells express CD11b. NOD and BALB/c
splenic cells were magnetically sorted into CD4
lo and CD4
hi
populations as detailed in the methods section. The non-CD4 cells
(MHCII
+CD8
+CD25
+) initially depleted in the sort were kept for
staining. (A) CD4
lo, CD4
hi and MHCII
+CD8
+CD25
+ cells were
stained for CD21 and CD19 (eBio8D9 and MB19-1; PE- and PE-
Cy5-conjugated, respectively, from eBioscience). Percentages
represent cells staining in upper right quadrant. Events were
ungated. (B) CD4
lo T cells from NOD and BALB/c were stained
for CD11c and CD11b (N418 and M1/70; FITC- and PE-
conjugated respectively.) Percentages represent cells staining in
upper left quadrant. Events were ungated. Quadrants in A and B
were set based on isotype controls.
Found at: doi:10.1371/journal.pone.0002076.s003 (0.26 MB PPT)
Figure S4 Bcl-XL expression in CD4
lo and CD4
hi T cells. Graph
representing the data in figure 5A and B. Data are represented as
mean6SEM from 3 separate experiments.
Found at: doi:10.1371/journal.pone.0002076.s004 (0.07 MB PPT)
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